Corcept Therapeutics Incorporated (FRA:HTD)

Corcept Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,219	5,100	3,029	2,046	1,844	2,484
Market Cap Growth	29.07%	68.36%	48.06%	10.92%	-25.77%	101.63%
Enterprise Value	6,773	4,577	2,654	1,672	1,410	2,124
Last Close Price	68.30	50.54	29.60	18.91	16.90	21.00
PE Ratio	80.93	37.78	31.74	21.59	18.64	28.67
PS Ratio	11.43	7.82	6.94	5.44	5.73	8.59
PB Ratio	13.40	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	13.40	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	51.93	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	51.84	26.66	26.36	18.17	12.49	20.00
EV/Sales Ratio	10.62	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	113.27	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	120.08	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	48.73	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.09	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.92	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.31	1.08	0.94	0.97	1.07	1.08
Quick Ratio	2.85	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.14	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	16.70%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	5.10%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	6.38%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	10.10%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	1.24%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	1.93%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-7.55%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.